PWMG
BLFS icon

Prestige Wealth Management Group’s BioLife Solutions BLFS Stock Holding History

Prestige Wealth Management Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-83
Closed -$1.15K – 1032
2023
Q3 		$1.15K Hold
83
– – ﹤0.01% 857
2023
Q2 		$1.83K Sell
83
-3
-3% -$63 ﹤0.01% 782
2023
Q1 		$1.87K Hold
86
– – ﹤0.01% 758
2022
Q4 		$1.56K Sell
86
-95
-52% -$1.96K ﹤0.01% 886
2022
Q3 		$4K Hold
181
– – ﹤0.01% 578
2022
Q2 		$2K Buy
+181
New +$2.66K ﹤0.01% 729

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prestige Wealth Management Group's BLFS Position: Q4 2023 in Review

Prestige Wealth Management Group sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 83 shares — an estimated $1.15K sold.

Prestige Wealth Management Group first reported a position in BLFS in Q2 2022 and held it in 6 quarters. The position peaked at $4K in Q3 2022. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • Prestige Wealth Management Group reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 83 BioLife Solutions shares in Q4 2023, an estimated $1.15K.
  • Prestige Wealth Management Group first reported a position in BioLife Solutions in Q2 2022 and held it in 6 quarters.
  • Prestige Wealth Management Group's BioLife Solutions position peaked at $4K in Q3 2022.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on Prestige Wealth Management Group's 13F filing for Q4 2023, filed 8 Feb 2024.